image credit: Adobe Stock

Johns Hopkins finds new AI blood test detects liver cancer in study

November 21, 2022

Johns Hopkins University School of Medicine in Maryland, US, has announced that a new artificial intelligence (AI)-based blood testing technology was found to detect more than 80% of liver cancers in a study.

The new blood test, dubbed DNA evaluation of fragments for early interception (DELFI), was developed and used by researchers at the Johns Hopkins Sidney Kimmel Cancer Center.

It has been designed for the detection of fragmentation changes that occur among DNA shed from cancer cells into the bloodstream, known as cell-free DNA (cfDNA).

Read More on Medical Device Network